Advertisement
  • Cancer Takes an Unequal Toll on Employment

    In a study of women with breast cancer in North Carolina, those who lived in rural areas or were black were more likely than urban white women to report negative changes in their employment.

    by Pamela Rafalow Grossman

  • Learning the Language of Chemotherapy

    Cancer patients often do not understand words their doctors use while talking about chemotherapy, but a new video series helps explain these terms.

    by Jen Tota McGivney

  • Navigating Hospital Discharge Decisions

    Patients with advanced cancer often go to rehabilitation facilities after a hospital stay in hopes of gaining the strength for further treatment, but the majority do not go on to receive additional cancer therapy, a study reports.

    by Ashley P. Taylor

  • Misunderstandings About Cancer DNA Tests

    Many cancer patients who received genomic testing of their cancers in a clinical trial did not fully understand the purpose of the testing.

    by Emma Yasinski

  • First Ladies of Africa Issue Call to Address Cancer Crisis

    A coalition of wives of African leaders, originally dedicated to addressing HIV/AIDS, is now also taking on the growing problem of cancer.

    by Bradley D. Miller, PhD

  • FORWARD LOOK

    Measuring Treatment Effectiveness

    Outcomes are often evaluated using progression-free survival.

    by Jasenka Piljac Zegarac

  • FORWARD LOOK

    New Option for Treating Pain From Bone Metastases

    Study supports use of single-session, higher-dose radiation.

    by Jane Langille

  • Finding More Targets for CAR-T Cells

    CAR-T cell therapy has successfully treated some patients with leukemia and lymphoma. Researchers are looking to expand the range of cancers that will respond to the therapy.

    by Kendall K. Morgan

  • FORWARD LOOK

    What’s Next?

    Researchers look for easier ways to screen for colorectal cancer in Nigeria.

    by Bradley Jones

  • Q&A

    The Promise of CRISPR

    Biochemist Samuel H. Sternberg describes the limitations, realities and potential of gene-editing technology.

    by Marci A. Landsmann

Advertisement

From the AACR

  • Targeting KRAS

    After decades of failed efforts to target the elusive KRAS, encouraging data suggest KRAS could finally be dethroned from the “undruggable” category.

  • New FDA Approval

    The U.S. Food and Drug Administration has approved an ovarian cancer treatment based on new biomarker.

  • Advances in Lung Cancer Research and Treatment

    Lung cancer—one of the most commonly diagnosed cancers in the United States—is an area of intense research and clinical development.

Advertisement

Video

Follow My Lead

Advertisement

social media

donate to the AACR